Phyto Chem (India) Limited (PHYTO.BO)
INR 33.4
(3.36%)
INR 33.4
(3.36%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 15.25 Million | 14.24 Million | 34.07 Million | -7.11 Million | 14.88 Million | 27.95 Million |
| Net Income | -33.3 Million | 2.64 Million | 1.97 Million | 4.66 Million | 4.22 Million | 9.04 Million |
| Depreciation & Amortization | 3.42 Million | 3.95 Million | 4.09 Million | 4.25 Million | 4.09 Million | 4.04 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 45.96 Million | -11.95 Million | 6.54 Million | -33.02 Million | -18.01 Million | -1.74 Million |
| Other non-cash items | 6.01 Million | 19.6 Million | 21.46 Million | 16.98 Million | 24.57 Million | 16.61 Million |
| Investing Cash Flow | -2.14 Million | 2.06 Million | 534 Thousand | 10.55 Million | -3.93 Million | -7.03 Million |
| Investments in PPE | -3.4 Million | -87 Thousand | -1.07 Million | -1.87 Million | -4.57 Million | -8.68 Million |
| Acquisitions | 828 Thousand | 333 Thousand | - | 13.41 Million | 63.45 Thousand | 261.42 Thousand |
| Investment purchases | -120 Thousand | 11 Thousand | -110 Thousand | -463 Thousand | 130.5 Thousand | -9.67 Million |
| Sales/Maturities of investments | - | 1 Million | - | 1.53 Million | 108.62 Thousand | 1.23 Million |
| Other Investing Activities | 555 Thousand | 797 Thousand | 1.71 Million | -2.06 Million | 338.41 Thousand | 9.83 Million |
| Financing Cash Flow | -12.14 Million | -17.02 Million | -34.48 Million | -3.97 Million | -11.02 Million | -20.68 Million |
| Debt repayment | -11.16 Million | -4.23 Million | -12.31 Million | -17.19 Million | -13.38 Million | -2.71 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -981 Thousand | -12.79 Million | -22.17 Million | 13.21 Million | 2.35 Million | -17.96 Million |
| Accounts receivables | - | - | - | - | - | -125.32 Million |
| Accounts payables | - | - | - | - | - | 146.5 Million |
| Inventory | - | - | - | - | - | -22.92 Million |
| Other working capital | 45.96 Million | -11.95 Million | 6.54 Million | -33.02 Million | -18.01 Million | 0.98 |
| Cash at beginning of period | 659 Thousand | 1.37 Million | 1.26 Million | 1.8 Million | 1.87 Million | 1.63 Million |
| Cash at end of period | 1.63 Million | 659 Thousand | 1.37 Million | 1.26 Million | 1.8 Million | 1.87 Million |
| Capital Expenditure | -3.4 Million | -87 Thousand | -1.07 Million | -1.87 Million | -4.57 Million | -8.68 Million |
| Effect of forex changes on cash | - | - | - | - | -4.00 | -2.00 |
| Net cash flow / Change in cash | 974 Thousand | -718 Thousand | 117 Thousand | -544 Thousand | -71.87 Thousand | 237.58 Thousand |
| Free Cash Flow | 11.85 Million | 14.15 Million | 32.99 Million | -8.98 Million | 10.31 Million | 19.26 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -33.3 Million | 2.92 Million | -1.6 Million | -17.56 Million | 1.22 Million | 2.64 Million |
| Depreciation & Amortization | 3.42 Million | 951 Thousand | 812 Thousand | 805 Thousand | 990 Thousand | 3.95 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 45.96 Million | - | - | - | - | -11.95 Million |
| Other non-cash items | 6.01 Million | -1.97 Million | -812 Thousand | -805 Thousand | -990 Thousand | 19.6 Million |
| Investing Cash Flow | -2.14 Million | - | - | - | - | 2.06 Million |
| Investments in PPE | -3.4 Million | - | - | - | - | -87 Thousand |
| Acquisitions | 828 Thousand | - | - | - | - | 333 Thousand |
| Investment purchases | -120 Thousand | - | - | - | - | 11 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | 1 Million |
| Other Investing Activities | 555 Thousand | - | - | - | - | 797 Thousand |
| Financing Cash Flow | -12.14 Million | - | - | - | - | -17.02 Million |
| Debt repayment | -11.16 Million | - | - | - | - | -4.23 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -981 Thousand | - | - | - | - | -12.79 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 45.96 Million | - | - | - | - | -11.95 Million |
| Cash at beginning of period | 659 Thousand | 1.95 Million | 3.56 Million | 659 Thousand | -565 Thousand | 1.37 Million |
| Cash at end of period | 1.63 Million | 3.86 Million | 1.95 Million | -17.56 Million | 659 Thousand | 659 Thousand |
| Capital Expenditure | -3.4 Million | - | - | - | - | -87 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 974 Thousand | 1.9 Million | -1.6 Million | -18.22 Million | 1.22 Million | -718 Thousand |
| Free Cash Flow | 11.85 Million | 1.9 Million | -1.6 Million | -17.56 Million | 1.22 Million | 14.15 Million |
DNN
SGMD
003220
ABBB
603323
CGRIF